IMAC HOLDINGS INC (IMAC) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:IMAC • US44967K1043

1.01 USD

+0.02 (+2%)

Last: Aug 5, 2022, 08:25 PM

Fundamental Rating

Taking everything into account, IMAC scores 2 out of 10 in our fundamental rating. IMAC was compared to 103 industry peers in the Health Care Providers & Services industry. IMAC may be in some trouble as it scores bad on both profitability and health. IMAC is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

IMAC had negative earnings in the past year.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	-48.41%
ROE	N/A
ROIC	-45.82%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

		Industry Rank	Sector Rank
OM	-72.27%
PM (TTM)	-76.98%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IMAC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for IMAC has been increased compared to 1 year ago.
Compared to 1 year ago, IMAC has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.90, we must say that IMAC is in the distress zone and has some risk of bankruptcy.
IMAC has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Altman-Z	-0.9

ROIC/WACC-5.63

WACC8.14%

2.3 Liquidity

IMAC has a Current Ratio of 1.27. This is a normal value and indicates that IMAC is financially healthy and should not expect problems in meeting its short term obligations.
IMAC has a Quick Ratio of 1.27. This is a normal value and indicates that IMAC is financially healthy and should not expect problems in meeting its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	1.27
Quick Ratio	1.27

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IMAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.64%, which is quite good.
Looking at the last year, IMAC shows a very strong growth in Revenue. The Revenue has grown by 21.05%.
The Revenue has been growing by 272.72% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)13.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%20%

Revenue 1Y (TTM)21.05%

Revenue growth 3Y29.01%

Revenue growth 5Y272.72%

Sales Q2Q%27.29%

3.2 Future

The Earnings Per Share is expected to grow by 2.32% on average over the next years.
The Revenue is expected to grow by 22.61% on average over the next years. This is a very strong growth

EPS Next Y2.98%

EPS Next 2Y7.43%

EPS Next 3Y4.29%

EPS Next 5Y2.32%

Revenue Next Year21.45%

Revenue Next 2Y23.21%

Revenue Next 3Y22.4%

Revenue Next 5Y22.61%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

IMAC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IMAC. No positive earnings are expected for the next year.